← FDA Drug Approvals (Drugs@FDA)
FLUDEOXYGLUCOSE F18
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NUKEMED · Approved 2015-04-22
Drug application
- FDA Application #
ANDA203911- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUDEOXYGLUCOSE F18
- Generic name
- Fludeoxyglucose F-18
- Active ingredients
- FLUDEOXYGLUCOSE F-18
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- NUKEMED
- First approval
- 2015-04-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown